Lumimeds
Sales Representative – Telehealth (Patient Conversion)
Remote - LATAM. Posted 5 months ago
The role
You will drive patient growth through warm inbound lead conversion and outbound outreach. You will manage the full conversion journey from first touch to scheduled calls using phone, SMS, chat, and email.
What you will do
- Convert warm inbound leads
- Conduct outbound calls to re-engage cold or inactive leads
- Proactively reach out to potential patients through structured outbound campaigns
- Engage via phone, SMS, chat, and email
- Educate patients using approved, non-clinical messaging
- Handle objections with empathy and confidence
- Manage your own pipeline and prioritize follow-ups
- Maintain accurate CRM documentation
- Meet and exceed daily, weekly, and monthly conversion and activity KPIs
- Collaborate with care and operations teams for seamless onboarding
Required qualifications
- 3+ years of sales experience (inside sales, telesales, or high-ticket sales)
- Proven remote sales experience
- Comfortable making 50+ calls per day when needed
- Strong hunter mentality with consultative selling ability
- Track record of meeting or exceeding sales targets
- Highly organized and self-motivated
- Professional-level English communication skills
- Comfortable working U.S. business hours
- Proficient with CRM systems, Slack, Dialpad, and spreadsheets
Nice to have
- Experience in telehealth, healthtech, SaaS, DTC, or wellness preferred
Benefits
- Base + uncapped commission
- Fully remote position
- Direct impact in one of the fastest-growing sectors in healthcare
- Startup culture where performance is recognized and rewarded
Before you apply
- Kindly send a Loom Video 30-sec of Self Introduction and Relevant Sales Experience
- Submit your application in English
- This position is open to candidates based in approved locations
About the company
LumiMeds is a fast-growing U.S.-based telehealth startup focused on weight management and long-term metabolic health. They are a remote-first, globally distributed team.